Clinical Trials Directory

Trials / Sponsors / Kathy Miller

Kathy Miller

Academic / Other · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingSOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer
Phase 22024-07-02
CompletedStudy of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastat
Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor
Phase 12020-04-01
CompletedAn Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
Triple Negative Breast Cancer, Metastatic Breast Cancer
Phase 12018-01-19
TerminatedMLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Hepatocellular Carcinoma, Liver Cancer, HCC
Phase 1 / Phase 22016-07-18
CompletedInhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy
Cancer of the Breast
Phase 22015-11-12
CompletedImpact of LOFT Therapy™ on Breast Cancer Survivors
Breast Neoplasms
N/A2015-07-28
TerminatedStudy Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
Bone Cancer, Metastasis
N/A2015-05-07
CompletedA Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Ly
Lymphedema
Phase 22009-01-01